SynthesisFrontiers in endocrinology2026

Metabolic dysfunction-associated steatohepatitis (MASH): intersections with type 2 diabetes and insulin resistance.

Nick GiannoukakisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.